Tuesday briefing: Palantir’s rise – and why so many oppose its role in the British state
In today’s newsletter: Its software is used from health services to militaries. But controversies and criticism of the $375bn company are leading some to ask if Palantir is too powerful Good morning. The Peter Mandelson story keeps unfolding. Peter Walker explains here what is in the latest release of documents, and Henry Dyer takes a look at the key papers missing from the latest disclosures. But today we are covering another major story – Palantir. Few companies attract controversy more than …
